M&G PLC Acadia Pharmaceuticals Inc Transaction History
M&G PLC
- $25.4 Trillion
- Q2 2024
A detailed history of M&G PLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, M&G PLC holds 351,115 shares of ACAD stock, worth $5.51 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
351,115
Previous 312,325
12.42%
Holding current value
$5.51 Million
Previous $5.62 Billion
0.07%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
288Shares Held
161MCall Options Held
723KPut Options Held
257K-
Baker Bros. Advisors LP New York, NY42.9MShares$673 Million9.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$215 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$215 Million3.72% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$189 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$91 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.54B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...